(Stroke. 1995;26:682-687.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Md; and Cook County Hospital, Chicago, Ill (R.F.G.).
Correspondence to Robert W. McPherson, MD, Meyer 8-138, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287.
Background and Purpose The role of nitric oxide in cerebrovascular response to changes in PCO2 is unclear. In the present study, we assessed responses at two levels of hypercapnia in a primate model before and after blockade of nitric oxide synthesis.
Methods We compared the effects of two levels of
hypercapnia, defined as PCO2 of
70 mm Hg
(high-CO2 group, n=5) and PCO2 of
50 mm Hg (moderate-CO2 group, n=6), on increases in
regional cerebral blood flow (microspheres) before and after inhibition
of nitric oxide synthase with
N
-nitro-L-arginine methyl ester
(L-NAME; 60 mg · kg-1) in isoflurane-anesthetized
cynomolgus monkeys (1.0% end-tidal concentration).
Results Before L-NAME administration, hypercapnia increased flow in all regions (eg, forebrain: high-CO2 group, 69±10 to 166±15 mL · min-1 · 100 g-1; moderate-CO2 group, 49±7 to 93±15 mL · min-1 · 100 g-1) and decreased cerebral vascular resistance (high-CO2, 1.1±0.1 to 0.4±0.1 mm Hg · mL-1 · min · 100 g; moderate-CO2, 1.4±0.1 to 0.7±0.1 mm Hg · mL-1 · min · 100 g). During normocapnia, L-NAME decreased cerebral blood flow (high-CO2, 37±9%; moderate-CO2, 40±6%) and increased cerebral vascular resistance (high-CO2, 93±33%; moderate-CO2, 88±20%). After L-NAME, hypercapnia still increased blood flow in all regions (eg, forebrain: high-CO2, 56±7 to 128±3 mL · min-1 · 100 g-1; moderate-CO2, 36±5 to 57±8 mL · min-1 · 100 g-1) and decreased vascular resistance (high-CO2, 1.5±0.1 to 0.6±0.1 mm Hg · mL-1 · min · 100 g; moderate-CO2, 2.0±0.3 to 1.2±0.1 mm Hg · mL-1 · min · 100 g). In both groups L-NAME attenuated hypercapnia hyperemia by approximately 30% in cortex but not in other regions.
Conclusions Nitric oxide contributes to basal vascular tone but is not a major contributor to the mechanism of hypercapnia-induced cerebral vasodilation, except in cortex, in primates.
Key Words: cerebral blood flow hypercapnia nitric oxide oxygen monkeys
This article has been cited by other articles:
![]() |
P. N. Ainslie, C. Murrell, K. Peebles, M. Swart, M. A. Skinner, M. J. A. Williams, and R. D. Taylor Vascular: Early morning impairment in cerebral autoregulation and cerebrovascular CO2 reactivity in healthy humans: relation to endothelial function Exp Physiol, July 1, 2007; 92(4): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Hoth, D. F. Tate, A. Poppas, D. E. Forman, J. Gunstad, D. J. Moser, R. H. Paul, A. L. Jefferson, A. P. Haley, and R. A. Cohen Endothelial Function and White Matter Hyperintensities in Older Adults With Cardiovascular Disease Stroke, February 1, 2007; 38(2): 308 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barkoudah, J. H. Jaggar, and C. W. Leffler The permissive role of endothelial NO in CO-induced cerebrovascular dilation Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1459 - H1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H S Markus Cerebral perfusion and stroke J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 353 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhardwaj, A. F. Castro III, N. J. Alkayed, P. D. Hurn, and J. R. Kirsch Anesthetic Choice of Halothane Versus Propofol: Impact on Experimental Perioperative Stroke Stroke, August 1, 2001; 32(8): 1920 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, A. M. Marrache, I. Dumont, P. Hardy, M. H. Beauchamp, X. Hou, K. Peri, F. Gobeil Jr, D. R. Varma, and S. Chemtob Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel- and Prostaglandin E2-Dependent Endothelial Nitric Oxide Synthase Induction Circ. Res., December 8, 2000; 87(12): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiss, S. Dallinger, O. Findl, G. Rainer, H.-G. Eichler, and L. Schmetterer Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1661 - R1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. White, C. Deane, P. Vallance, and H. S. Markus Nitric Oxide Synthase Inhibition in Humans Reduces Cerebral Blood Flow but Not the Hyperemic Response to Hypercapnia Stroke, February 1, 1998; 29(2): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, C. Iadecola, and F. M. Faraci Activation of Cerebellar Climbing Fibers Increases Cerebellar Blood Flow : Role of Glutamate Receptors, Nitric Oxide, and cGMP • Editorial Comment: Role of Glutamate Receptors, Nitric Oxide, and cGMP Stroke, February 1, 1998; 29(2): 499 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schmetterer, O. Findl, K. Strenn, U. Graselli, J. Kastner, H.-G. Eichler, and M. Wolzt Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R2005 - R2012. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kinoshita, Z. S. Katusic, and E. P. Wei Role of Potassium Channels in Relaxations of Isolated Canine Basilar Arteries to Acidosis Stroke, February 1, 1997; 28(2): 433 - 438. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |